keyword
MENU ▼
Read by QxMD icon Read
search

Prostate cancer mortality epidemiology

keyword
https://www.readbyqxmd.com/read/29777564/the-importance-of-non-regional-lymph-nodes-in-assigning-risk-in-primary-metastatic-prostate-cancer
#1
Adnan Ali, Alexander Hoyle, Hitesh Mistry, Noel W Clarke
OBJECTIVE: To determine the prognostic relevance of non-regional lymph nodes (NRLN) metastases presenting synchronously with bone metastases in metastatic prostate cancer (mPCa) for guiding treatment decisions based on oligometastatic definitions. PATIENTS AND METHODS: Patients diagnosed with mPCa between 2004 and 2013 were identified from the surveillance, epidemiology and end-results (SEER) database and were grouped by metastatic sites into only NRLN, only bone, bone + NRLN and other sites ± bone/NRLN metastases...
May 19, 2018: BJU International
https://www.readbyqxmd.com/read/29740894/epidemiology-of-prostate-cancer-in-asian-countries
#2
REVIEW
Takahiro Kimura, Shin Egawa
The incidence of prostate cancer has been increasing worldwide in recent years. The GLOBOCAN project showed that prostate cancer was the second most frequently diagnosed cancer and the fifth leading cause of cancer mortality among men worldwide in 2012. This trend has been growing even in Asian countries, where the incidence had previously been low. However, the accuracy of data about incidence and mortality as a result of prostate cancer in some Asian countries is limited. The cause of this increasing trend is multifactorial...
May 8, 2018: International Journal of Urology: Official Journal of the Japanese Urological Association
https://www.readbyqxmd.com/read/29724482/physician-visits-and-the-timing-of-skeletal-related-events-among-men-newly-diagnosed-with-metastatic-prostate-cancer-a-cohort-analysis
#3
Eberechukwu Onukwugha, Husam Albarmawi, Kai Sun, C Daniel Mullins, Abdalla Aly, Arif Hussain
INTRODUCTION: Men diagnosed with metastatic prostate cancer (PCa) are at increased risk for skeletal complications which are associated with significant morbidity and mortality. Although both the urologist and the medical oncologist play important roles in the management of patients with advanced PCa, there is limited information regarding their role in the context of skeletal complications. The current study investigated these relationships among newly diagnosed metastatic patients with PCa...
April 30, 2018: Urologic Oncology
https://www.readbyqxmd.com/read/29723398/trends-in-incidence-and-5-year-mortality-in-men-with-newly-diagnosed-metastatic-prostate-cancer-a-population-based-analysis-of-2-national-cohorts
#4
John T Helgstrand, Martin A Røder, Nina Klemann, Birgitte G Toft, Daphne Y Lichtensztajn, James D Brooks, Klaus Brasso, Ben Vainer, Peter Iversen
BACKGROUND: Early detection has increased prostate cancer (PCa) incidence. Randomized trials have demonstrated that early detection reduces the incidence of de novo metastatic PCa. Concurrently, life-prolonging treatments have been introduced for patients with advanced PCa. On a populations-based level, the authors analyzed whether early detection and improved treatments changed the incidence and 5-year mortality of men with de novo metastatic PCa. METHODS: Men diagnosed with PCa during the periods 1980 to 2011 and 1995 to 2011 were identified in the US Surveillance, Epidemiology, and End Results (SEER) program and the Danish Prostate Cancer Registry (DaPCaR), respectively, and stratified according to period of diagnosis...
May 3, 2018: Cancer
https://www.readbyqxmd.com/read/29574909/iron-status-in-relation-to-cancer-risk-and-mortality-findings-from-a-population-based-prospective-study
#5
Daniel A Quintana Pacheco, Disorn Sookthai, Mirja E Graf, Ruth Schübel, Theron Johnson, Verena Katzke, Rudolf Kaaks, Tilman Kühn
While experimental evidence suggests potential carcinogenic effects of increased iron load, there is a lack of data on iron status and cancer risk from epidemiological studies. Here, we evaluated pre-diagnostic serum concentrations of ferritin, iron, and transferrin as well as transferrin saturation (TSAT) in relation to cancer risk and mortality in a prospective study by multivariable Cox regression analyses. A case-cohort sample of the population-based EPIC-Heidelberg Study including a random subcohort (n=2738) and incident cases of breast cancer (n=627), prostate cancer (n=554), lung cancer (n=195), colorectal cancer (n=256), and cancer death (n=759) was used...
March 25, 2018: International Journal of Cancer. Journal International du Cancer
https://www.readbyqxmd.com/read/29552113/marital-status-independently-predicts-prostate-cancer-survival-in-men-who-underwent-radical-prostatectomy-an-analysis-of-95-846-individuals
#6
Tian-Bao Huang, Guang-Chen Zhou, Chuan-Peng Dong, Li-Ping Wang, Yang Luan, Jing-Ting Ye, Xiao Gu, Xu-Dong Yao, Jun-Hua Zheng, Xue-Fei Ding
Marital status is an independent prognostic factor for survival in several types of cancer, but has not been fully studied in prostate cancer (PCa). A total of 95,846 men diagnosed with PCa were treated with radical prostatectomy (RP) between 2004 and 2009 within 18 Surveillance, Epidemiology and End Results registries. Survival curves were generated using Kaplan-Meier estimates and differences in survival were assessed using the log-rank test. Cox regression models were used to assess the impact of marital status on survival outcomes...
April 2018: Oncology Letters
https://www.readbyqxmd.com/read/29494336/telomere-biology-and-age-related-diseases
#7
REVIEW
Markus Herrmann, Irene Pusceddu, Winfried März, Wolfgang Herrmann
Telomeres are the protective end caps of chromosomes and shorten with every cell division. Telomere length has been proposed as a biomarker of biological age and a risk factor for age-related diseases. Epidemiologic studies show an association between leukocyte telomere length (LTL) and mortality. There is solid evidence that links LTL with cardiovascular disease. Short telomeres promote atherosclerosis and impair the repair of vascular lesions. Alzheimer's disease patients have also a reduced LTL. Telomeres measured in tumor tissue from breast, colon and prostate are shorter than in healthy tissue from the same organ and the same patient...
March 1, 2018: Clinical Chemistry and Laboratory Medicine: CCLM
https://www.readbyqxmd.com/read/29493549/the-performance-of-the-new-prognostic-grade-and-stage-groups-in-conservatively-treated-prostate-cancer
#8
Cheng Chen, Ye Chen, Lin-Kun Hu, Chang-Chuan Jiang, Ren-Fang Xu, Xiao-Zhou He
We evaluated the prognosis of the new grade groups and American Joint Committee on Cancer (AJCC) stage groups in men with prostate cancer (PCa) who were treated conservatively. A total of 13 798 eligible men were chosen from the Surveillance Epidemiology and End Results database. The new grade and AJCC stage groups were investigated on prostate biopsy specimens. Kaplan-Meier survival analysis and multivariable hazards models were applied to estimate the association of new grade and stage groups with overall survival (OS) and PCa-specific survival (CSS)...
February 27, 2018: Asian Journal of Andrology
https://www.readbyqxmd.com/read/29479835/racial-ethnic-disparities-in-de-novo-metastases-sites-and-survival-outcomes-for-patients-with-primary-breast-colorectal-and-prostate-cancer
#9
Tomi Akinyemiju, Swati Sakhuja, John Waterbor, Maria Pisu, Sean F Altekruse
Racial disparities in cancer mortality still exist despite improvements in treatment strategies leading to improved survival for many cancer types. In this study, we described race/ethnic differences in patterns of de novo metastasis and evaluated the association between site of de novo metastasis and breast, prostate, and colorectal cancer mortality. Data were obtained from the Surveillance Epidemiology and Ends Results (SEER) database from 2010 to 2013 and included 520,147 patients ages ≥40 years with primary diagnosis of breast, colorectal, or prostate cancer...
April 2018: Cancer Medicine
https://www.readbyqxmd.com/read/29478736/clinical-and-genomic-characterization-of-low-prostate-specific-antigen-high-grade-prostate-cancer
#10
Brandon A Mahal, David D Yang, Natalie Q Wang, Mohammed Alshalalfa, Elai Davicioni, Voleak Choeurng, Edward M Schaeffer, Ashley E Ross, Daniel E Spratt, Robert B Den, Neil E Martin, Kent W Mouw, Peter F Orio, Toni K Choueiri, Mary-Ellen Taplin, Quoc-Dien Trinh, Felix Y Feng, Paul L Nguyen
BACKGROUND: The consequences of low prostate-specific antigen (PSA) in high-grade (Gleason 8-10) prostate cancer are unknown. OBJECTIVE: To evaluate the clinical implications and genomic features of low-PSA, high-grade disease. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective study of clinical data for 494 793 patients from the National Cancer Data Base and 136 113 patients from the Surveillance, Epidemiology, and End Results program with cT1-4N0M0 prostate cancer (median follow-up 48...
February 22, 2018: European Urology
https://www.readbyqxmd.com/read/29474521/ethnic-differences-in-tgf%C3%AE-signaling-pathway-may-contribute-to-prostate-cancer-health-disparity
#11
Bethtrice Elliott, DeAdra L Zackery, Vanessa A Eaton, Re'Josef T Jones, Fisseha Abebe, Camille C Ragin, Shafiq A Khan
Epidemiological studies show that the incidence and mortality rates of prostate cancer (PCa) are significantly higher in African-American (AA) men when compared with Caucasian (CA) men in the United States. Transforming growth factor β (TGFβ) signaling pathway is linked to health disparities in AAs. Recent studies suggest a role of TGFβ3 in cancer metastases and its effect on the migratory and invasive behavior; however, its role in PCa in AA men has not been studied. We determined the circulating levels of TGFβ3 in AA and CA men diagnosed with PCa using ELISA...
April 5, 2018: Carcinogenesis
https://www.readbyqxmd.com/read/29460290/extent-of-lymph-node-dissection-improves-survival-in-prostate-cancer-patients-treated-with-radical-prostatectomy-without-lymph-node-invasion
#12
Felix Preisser, Marco Bandini, Michele Marchioni, Sebastiano Nazzani, Zhe Tian, Raisa S Pompe, Nicola Fossati, Alberto Briganti, Fred Saad, Shahrokh F Shariat, Hans Heinzer, Hartwig Huland, Markus Graefen, Derya Tilki, Pierre I Karakiewicz
PURPOSE: To assess the effect of pelvic lymph node dissection (PLND) extent on cancer-specific mortality (CSM) in prostate cancer (PCa) patients without lymph node invasion (LNI) treated with radical prostatectomy (RP). METHODS: Within the Surveillance, Epidemiology, and End results (SEER) database (2004-2014), we identified patients with D'Amico intermediate- or high-risk characteristics who underwent RP with PLND, without evidence of LNI. First, multivariable logistic regression models tested for predictors of more extensive PLND, defined as removed lymph node count (NRN) ≥75th percentile...
May 2018: Prostate
https://www.readbyqxmd.com/read/29459359/impact-of-dietary-patterns-and-the-main-food-groups-on-mortality-and-recurrence-in-cancer-survivors-a-systematic-review-of-current-epidemiological-literature
#13
Sylvia H J Jochems, Frits H M Van Osch, Richard T Bryan, Anke Wesselius, Frederik J van Schooten, Kar Keung Cheng, Maurice P Zeegers
OBJECTIVE: To determine whether there is an association between dietary patterns/indices and foods from the main food groups (highest vs lowest intakes) prior to or after cancer diagnosis and mortality and cancer recurrence in cancer survivors. PARTICIPANTS: Survivors of common cancers with a 10-year survival rate of ≥50%: bladder, bowel, breast, cervical, kidney, laryngeal, prostate, testicular, uterine cancer, malignant melanoma and (non-)Hodgkin's lymphoma...
February 19, 2018: BMJ Open
https://www.readbyqxmd.com/read/29433825/risk-factors-for-prostate-cancer-a-multifactorial-case-control-study
#14
Saima Shakil Malik, Rakshanda Batool, Nosheen Masood, Azra Yasmin
Prostate cancer is the third most commonly diagnosed cancer among Pakistani men. It is a multifactorial disease involving genetics together with environmental factors. Countries where men have greater dietary fat intake showed increased prostate cancer mortality rates. A population based case-control study was conducted to evaluate various prostate cancer risk factors. Study subjects were 896 prostate cancer cases (2010-2015) and 900 age matched controls. Odds ratio (OR) and 95% CI were used to estimate the association between different risk factors and prostate cancer...
February 9, 2018: Current Problems in Cancer
https://www.readbyqxmd.com/read/29426698/external-beam-radiotherapy-with-or-without-androgen-deprivation-therapy-in-elderly-patients-with-high-metastatic-risk-prostate-cancer
#15
Paolo Dell'Oglio, Marco Bandini, Sami-Ramzi Leyh-Bannurah, Zhe Tian, Vincent Trudeau, Alessandro Larcher, Nicola Fossati, Marco Moschini, Giorgio Gandaglia, Umberto Capitanio, Alberto Briganti, Markus Graefen, Francesco Montorsi, Fred Saad, Pierre I Karakiewicz
OBJECTIVE: Several randomized controlled trials have documented significant overall survival benefit in high metastatic risk prostate cancer (PCa) patients treated with combination of androgen deprivation therapy (ADT) at radiotherapy (RT) relative to RT alone. Unfortunately, elderly patients are either not included or are underrepresented in these trials. In consequence, the survival benefit of combination of ADT at RT in the elderly warrants detailed reassessment, including its cost...
February 6, 2018: Urologic Oncology
https://www.readbyqxmd.com/read/29410239/what-the-oncologist-can-learn-from-diabetes-studies-epidemiology-prevention-management-cure
#16
REVIEW
Adriana Albini, Marco Gallo
Notwithstanding massive efforts and investment in improving cancer therapy, the limited progress made in reducing overall mortality has mostly been achieved through early diagnosis. Mortality rates for cardiovascular disease are in decline, a success attributable in large part to an active prevention approach coupled with identification of risk factors and biomarkers. Promising natural and synthetic molecules including numerous flavonoids have the potential to be used in diabetes care and in prevention of cardiovascular pathologies...
February 2, 2018: Diabetes Research and Clinical Practice
https://www.readbyqxmd.com/read/29366856/contemporary-trends-and-survival-outcomes-after-aborted-radical-prostatectomy-in-lymph-node-metastatic-prostate-cancer-patients
#17
Marco Bandini, Felix Preisser, Sebastiano Nazzani, Michele Marchioni, Zhe Tian, Nicola Fossati, Giorgio Gandaglia, Andrea Gallina, Firas Abdollah, Shahrokh F Shariat, Francesco Montorsi, Fred Saad, Derya Tilki, Alberto Briganti, Pierre I Karakiewicz
BACKGROUND: Aborted radical prostatectomy (aRP) in lymph node (LN) metastatic (pN1) prostate cancer (PCa) patients showed worse survival in European patients. Contemporary rates of aRP are unknown in North America. OBJECTIVE: To examine the rate of aRP and its effect on cancer-specific mortality (CSM) in contemporary North American patients. DESIGN, SETTING, AND PARTICIPANTS: Within the Surveillance Epidemiology and End Results database (2004-2014), we identified 3719 pN1 PCa patients...
January 20, 2018: European Urology Focus
https://www.readbyqxmd.com/read/29358783/prostate-cancer-incidence-and-mortality-in-navarre-spain
#18
J Etxeberria, M Guevara, C Moreno-Iribas, R Burgui, I Delfrade, Y Floristán, M Montesino, E Ardanaz
BACKGROUND: Prostate cancer is one of the most commonly diagnosed malignancies among males worldwide. In this study, overall and age-specific incidence and mortality trends are analyzed in order to present the past and current epidemiological situation of the disease in Navarre (Spain). METHODS: Population-based incidence data from the 1975-2010 period, provided by the Cancer Registry of Navarre and prostate cancer specific mortality data for 1975-2013, provided by the Spanish Statistical Office, were used in the analysis...
January 23, 2018: Anales del Sistema Sanitario de Navarra
https://www.readbyqxmd.com/read/29339806/tumor-characteristics-treatments-and-oncological-outcomes-of-prostate-cancer-in-men-aged-%C3%A2-50-years-a-population-based-study
#19
Raisa S Pompe, Ariane Smith, Marco Bandini, Michele Marchioni, Tristan Martel, Felix Preisser, Sami-Ramzi Leyh-Bannurah, Jonas Schiffmann, Fred Saad, Hartwig Huland, Markus Graefen, Shahrokh F Shariat, Derya Tilki, Pierre I Karakiewicz
BACKGROUND: To examine clinical characteristics, treatment modalities and oncological outcomes of prostate cancer (PCa) according to young (≤50) vs. old age. METHODS: Of 407,599 men with primary adenocarcinoma of the prostate within the Surveillance, Epidemiology and End Results (SEER)-database (2004 to 2013), 18,387 were aged ≤50 years (4.5%). Time trends, cumulative incidence, and competing risks regression (CRR) analyses tested for differences between young and old patients...
April 2018: Prostate Cancer and Prostatic Diseases
https://www.readbyqxmd.com/read/29311132/the-epidemiology-of-prostate-cancer
#20
Claire H Pernar, Ericka M Ebot, Kathryn M Wilson, Lorelei A Mucci
Prostate cancer is a major cause of disease and mortality among men, and each year 1.6 million men are diagnosed with and 366,000 men die of prostate cancer. In this review, we discuss the state of evidence for specific genetic, lifestyle, and dietary factors associated with prostate cancer risk. Given the biological heterogeneity of this cancer, we focus on risk factors for advanced or fatal prostate cancer. First, we provide descriptive epidemiology statistics and patterns for prostate cancer incidence and mortality around the world...
January 8, 2018: Cold Spring Harbor Perspectives in Medicine
keyword
keyword
74132
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"